- Home
- IVA vs MRAM Comparison
IVA vs MRAM Comparison
Compare IVA & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- MRAM
- Stock Information
- Founded
- IVA 2011
- MRAM 2008
- Country
- IVA France
- MRAM United States
- Employees
- IVA N/A
- MRAM N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- MRAM Semiconductors
- Sector
- IVA Health Care
- MRAM Technology
- Exchange
- IVA Nasdaq
- MRAM Nasdaq
- Market Cap
- IVA 359.6M
- MRAM 114.4M
- IPO Year
- IVA 2020
- MRAM 2016
- Fundamental
- Price
- IVA $3.01
- MRAM $6.84
- Analyst Decision
- IVA Strong Buy
- MRAM Strong Buy
- Analyst Count
- IVA 4
- MRAM 1
- Target Price
- IVA $10.50
- MRAM $8.00
- AVG Volume (30 Days)
- IVA 18.3K
- MRAM 222.2K
- Earning Date
- IVA 03-26-2025
- MRAM 07-30-2025
- Dividend Yield
- IVA N/A
- MRAM N/A
- EPS Growth
- IVA N/A
- MRAM N/A
- EPS
- IVA N/A
- MRAM N/A
- Revenue
- IVA $14,591,573.00
- MRAM $49,110,000.00
- Revenue This Year
- IVA $15.38
- MRAM $9.48
- Revenue Next Year
- IVA $24.22
- MRAM $12.85
- P/E Ratio
- IVA N/A
- MRAM N/A
- Revenue Growth
- IVA N/A
- MRAM N/A
- 52 Week Low
- IVA $1.53
- MRAM $4.34
- 52 Week High
- IVA $4.05
- MRAM $7.02
- Technical
- Relative Strength Index (RSI)
- IVA 40.84
- MRAM 68.59
- Support Level
- IVA $3.00
- MRAM $6.00
- Resistance Level
- IVA $3.23
- MRAM $7.02
- Average True Range (ATR)
- IVA 0.21
- MRAM 0.28
- MACD
- IVA -0.04
- MRAM 0.08
- Stochastic Oscillator
- IVA 5.08
- MRAM 86.36
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).